key: cord-0689923-4bgl40ir
authors: Mitra, Anita
title: Blood clots, COVID-19 vaccines and the contraceptive pill: are we heading for a repeat of the 1995 pill scare?
date: 2021-06-22
journal: BMJ Sex Reprod Health
DOI: 10.1136/bmjsrh-2021-201219
sha: e9fbd5ac2409ecd8c3c6e9eb6f489c1732d93dca
doc_id: 689923
cord_uid: 4bgl40ir

nan

Blood clots, COVID-19 vaccines and the contraceptive pill: are we heading for a repeat of the 1995 pill scare?

There has been a wealth of media coverage regarding venous thromboembolism (VTE) following certain types of COVID-19 vaccines in the mainstream media and online. To put the risk into perspective for the general public, many journalists, authors and even scientific journals have used the risk of VTE associated with 'the contraceptive pill' and air travel as comparators. While this may be well-meaning, it is an unjust comparison and may have unintended consequences on contraceptive use and unplanned pregnancies.

Such alarming headlines can be emotive to contraceptive users. VTE associated with hormonal contraceptive use generally relates to deep vein thrombosis and pulmonary embolism, which is quite a different clinical picture to the cerebral venous sinus thromboses (CVST) being reported in individuals receiving the AstraZeneca vaccine that also appear to arise by a different mechanism. 1 The complications are neither similar conditions, nor have similar outcomes with CVST, being associated with much higher mortality than combined hormonal contraception (CHC)-related VTE. In addition, such a comparison does not make any distinction between CHC, which does carry a 2-5-fold increased risk of VTE, and progestogen-only pills, which do not increase the background risk. 2 Furthermore, while CHC does increase an individual's risk of VTE, it reduces the overall number of episodes of VTE in the population and healthcare-related spend due to the reduction in the number of pregnancies, which are associated with a risk of VTE greater than that of a CHC user. 3 To evaluate how such headlines may impact contraceptive behaviours, an informal online poll of social media users was conducted on 18 April 2021 via the Instagram account @gynaegeek, which is followed by over 148 000 predominantly UK-based females. The poll, available for 24 hours, posed the question: "A quick question to all contraceptive pill users: Have the discussions about blood clots and COVID-19 vaccines and the comparison between blood clots and the contraceptive pill caused you to actually stop or consider stopping your pill?".

From a total of 10 193 responses, 38% responded 'Yes' (n=3853) and 62% responded 'No' (n=6340).

In October 1995, the UK Committee on Safety of Medicines issued a warning that use of third-generation combined oral contraceptive pills (COCPs) containing gestodene or desogestrel carried a greater VTE risk than COCPs containing other progestogens. Prior to this, the trend in conception rates in England and Wales had been decreasing since 1990, yet in 1996 there were 26 000 more conceptions than in 1995, with an increase of 7%, 4% and 2%, respectively, in the first three quarters of the year, compared with the same periods in the previous year. Furthermore, data relating to abortions demonstrated that an additional 13 601 pregnancies were terminated in the same year: an increase of 8% from 1995. Again, this was in stark contrast to the progressive decline in abortion rates recorded since 1990. 4 While contraceptive users deserve to be fully informed about the risks and benefits of the various contraceptive types, representation of these in the media should not result in a negative impact on public health, as was clearly inferred by the spike in conception and termination rates seen in 1996.

Based on the responses of the 10 193 social media users, we may observe an increase in the number of women wishing to discontinue hormonal contraception in the light of the recent headlines. It is important for clinicians and contraceptive providers to be aware of the ideas and opinions of contraceptive users so that we can adequately address their concerns and ensure they have access to information regarding effective alternative options in a bid to subvert a repeat of the health impact demonstrated by the 1995 pill scare.

In March 2020, as COVID-19 rapidly spread across the United States, a singular question emerged: What are essential services? While antichoice lawmakers attempted to classify abortion as non-essential despite professional medical associations affirming abortion to be essential, timesensitive healthcare, little attention was paid to crisis pregnancy centres (CPCs). CPCs purport to assist 'vulnerable' pregnant people, but many use medical misinformation and misleading tactics to discourage pregnant people from abortion. 1 Many CPCs attempt to present as medical offices, but most are staffed by unlicensed volunteers who provide over-the-counter pregnancy tests and non-diagnostic ('keepsake') ultrasounds. 1 Their number is rapidly increasing and fuelled by public funding; CPCs now vastly outnumber abortion clinics nationwide. 1 The Alliance: State Advocates for Women's Rights & Gender Equality is a collaboration of four state-based law and policy centres working for gender equality (Gender Justice, Legal Voice, Southwest Women's Law Center and Women's Law Project). With CPC project partner California Women's Law Center, The Alliance maintains a database of CPCs in nine states (Alaska, California, Idaho, Minnesota, Montana, New Mexico, Oregon, Pennsylvania and Washington) using online searches, CPC network websites and national CPC databases. 2 3 We documented the operating status of these CPCs from 15 April-5 June 2020, when non-essential services were generally closed 4 5 due to the pandemic, by reviewing CPC websites and social media.

We collected data from 537 CPCs in eight states. Most data (90.1%) were collected prior to reopening of essential services; collection of the remaining data (9.9%) began during shutdowns and concluded within 18 days of reopening. 4 We excluded New Mexico because its shutdown was lifted early during data collection.

CPC operating status is shown in figure 1 ; we found 59.2% of CPCs open for in-person visits. While healthcare services were broadly defined as essential in all study states, 5 it is unclear whether open CPCs met even broad definitions of essential healthcare. Most provided pregnancy testing (87.4%) and counselling (87.7%), but the urine tests many CPCs provide are available over-the-counter, and most CPC counselling appears to be provided by 'peers' as opposed to licensed professionals. Some open CPCs did not offer even these limited services, and almost none offered well-person care (3.1%), prenatal care (1.7%) or contraception (0.6%). Only 49% of open CPC websites indicated a licensed professional was on staff; thus it is unclear what essential medical services the remaining 51% could provide.

Study limitations include (1) inability to ascertain operating status of nearly 30% of CPCs, (2) lack of generalisability given most study states' location in the western United States, (3) possibility of missed CPCs in project states despite using multiple sources to identify CPCs, (4) difficulty firmly establishing how CPCs were viewed by local lawmakers during the shutdowns and (5) collection of <10% of data after official reopening of non-essential services, though findings were materially unchanged when excluding these data.

In an era defined by urgent debate about what is an essential service, there was no apparent public discussion about CPCs by public officials overwhelmed by the COVID-19 emergency, and decisions to stay open amid the spreading pandemic were evidently left to the CPCs themselves. In light of continued uncertainty about the pandemic's

The impact of COVID-19 on services for people affected by sexual and genderbased violence

COVID-19, lockdown, and intimate partner violence: some data from an Italian service and suggestions for future approaches

AstraZeneca's COVID-19 vaccine: benefits and risks in context

2 Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. FSRH clinical guideline: combined hormonal contraception

Mortality associated with fertility and fertility control: 1983

Trends in conceptions before and after the 1995 pill scare